This inventor holds 4 USPTO granted patents. Top assignees: Edna Mcconnell Clark Foundation, Warner-Lambert Company. Active years: 1980-1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980-1986
Title: **The Innovations of Donald F. Worth: A Leader in Medicinal Chemistry**
Introduction
Donald F. Worth, an accomplished inventor based in Ann Arbor, Michigan, has made significant contributions to the field of medicinal chemistry. With a portfolio that includes four patents, Worth’s work primarily focuses on developing novel compounds with antimicrobial properties and potential therapeutic applications in treating various infections and cancers.
Latest Patents
Among his latest patents, Worth has developed compounds such as antibacterial benzo(chalcogeno)[4,3,2-cd]indazoles, substituted 2H-[1]benzopyrano[4,3,2-cd]indazoles, 2H-[1]benzothiopyrano[4,3,2-cd]indazoles, and 2H-[1]benzoselenino[4,3,2-cd]indazoles. These innovative compounds have demonstrated pharmacological activity against a wide spectrum of Gram-positive and Gram-negative bacteria, yeasts, and fungi. Additionally, they exhibit activity against L1210 and P388 murine leukemia cell lines. Worth’s patents disclose not only the compounds but also pharmaceutical compositions and methods for employing these innovations to treat bacterial or fungal infections and inhibit the growth of neoplasms in mammals. Another notable patent includes anti-bacterial 1,4-aminoalkylamino-9H-thioxanthen-9-one derivatives, which also show antimicrobial activity and efficacy against leukemic cells, alongside methods for their preparation and use.
Career Highlights
Throughout his career, Worth has been associated with esteemed organizations such as the Edna McConnell Clark Foundation and Warner-Lambert Company. At these firms, he played substantial roles in advancing research initiatives aimed at discovering and developing new medicinal compounds.
Collaborations
In his innovative pursuits, Worth has collaborated with notable colleagues, including Leslie M. Werbel and Norman Colbry. Their combined expertise has contributed to the success of numerous research projects and advancements in pharmaceutical sciences.
Conclusion
With a robust patent portfolio and a history of collaboration in the pharmaceutical field, Donald F. Worth exemplifies the spirit of innovation within the realm of medicinal chemistry. His contributions not only advance scientific understanding but also hold the promise of improving healthcare outcomes through the development of effective treatments for bacterial, fungal infections, and certain cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile